Literature DB >> 32475990

Multiple myeloma and COVID-19.

Binod Dhakal1, Anita D'Souza2, Saurabh Chhabra2, Parameswaran Hari2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32475990     DOI： 10.1038/s41375-020-0879-9

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2020-06-27       Impact factor: 9.079

2.  COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia.

Authors:  Lindsey E Roeker; David A Knorr; Meghan C Thompson; Mariely Nivar; Sonia Lebowitz; Nicole Peters; Isaac Deonarine; Saddia Momotaj; Saumya Sharan; Vanessa Chanlatte; Bianca Hampton; Liana Butala; Lindsay Amato; Angela Richford; Jessica Lunkenheimer; Kristen Battiato; Carissa Laudati; Anthony R Mato
Journal:  Leukemia       Date:  2021-05-13       Impact factor: 11.528

Review 3.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

4.  Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Authors:  Nicola Giesen; Rosanne Sprute; Maria Rüthrich; Yascha Khodamoradi; Sibylle C Mellinghoff; Gernot Beutel; Catherina Lueck; Michael Koldehoff; Marcus Hentrich; Michael Sandherr; Michael von Bergwelt-Baildon; Hans-Heinrich Wolf; Hans H Hirsch; Bernhard Wörmann; Oliver A Cornely; Philipp Köhler; Enrico Schalk; Marie von Lilienfeld-Toal
Journal:  Eur J Cancer       Date:  2020-09-21       Impact factor: 9.162

5.  COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients.

Authors:  Jennifer A Belsky; Brian P Tullius; Margaret G Lamb; Rouba Sayegh; Joseph R Stanek; Jeffery J Auletta
Journal:  J Infect       Date:  2021-02-04       Impact factor: 6.072

6.  Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.

Authors:  Nophol Leelayuwatanakul; Napplika Kongpolprom; Thitiwat Sriprasart; Vorakamol Phoophiboon; Vorawut Thanthitaweewat; Sarita Thawanaphong; Worawan Sirichana; Naricha Chirakalwasan; Kamon Kawkitinarong; Chanchai Sittipunt; Opass Putcharoen; Leilani Paitoonpong; Gompol Suwanpimolkul; Watsamon Jantarabenjakul; Nattachai Srisawat; Monvasi Pachinburavan
Journal:  Respirol Case Rep       Date:  2021-03-07

7.  COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia.

Authors:  Quinto Gesiotto; Asima Cheema; Kishan Avaiya; Bijal Shah; John Greene
Journal:  Cureus       Date:  2021-05-26

8.  Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?

Authors:  Imran K Tailor; Nawal F Alshehry; Syed Z Zaidi; Mohammed A Marei; Ibraheem H Motabi; Mansour Alfayez; Syed Y Altaf
Journal:  Hematol Oncol Stem Cell Ther       Date:  2020-09-16

9.  The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma.

Authors:  Hesham Elsabah; Mahmood B Aldapt; Ruba Taha; Dina S Soliman; Halima Elomri; Feryal Ibrahim
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

10.  The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.

Authors:  Holly Lee; Jason Tay; Peter Duggan; Sylvia McCulloch; Paola Neri; Nizar J Bahlis; Victor H Jimenez-Zepeda
Journal:  Eur J Haematol       Date:  2020-11-29       Impact factor: 3.674
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.